Header Logo

Connection

Carl Maki to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Carl Maki has written about Xenograft Model Antitumor Assays.
Carl Maki
Connection Strength
0.053
Xenograft Model Antitumor Assays
  1. Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles. Proc Natl Acad Sci U S A. 2022 09 20; 119(38):e2205454119.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.